Mankind Pharma Statistics

Total Valuation

Mankind Pharma has a market cap or net worth of INR 1.02 trillion. The enterprise value is 1.08 trillion.

Market Cap	1.02T
Enterprise Value	1.08T

Important Dates

The last earnings date was Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Mankind Pharma has 412.67 million shares outstanding. The number of shares has increased by 0.87% in one year.

Current Share Class	412.67M
Shares Outstanding	412.67M
Shares Change (YoY)	+0.87%
Shares Change (QoQ)	+2.62%
Owned by Insiders (%)	57.73%
Owned by Institutions (%)	18.45%
Float	105.97M

Valuation Ratios

The trailing PE ratio is 50.15 and the forward PE ratio is 48.46. Mankind Pharma's PEG ratio is 3.27.

PE Ratio	50.15
Forward PE	48.46
PS Ratio	8.32
PB Ratio	6.97
P/TBV Ratio	n/a
P/FCF Ratio	52.03
P/OCF Ratio	42.10
PEG Ratio	3.27

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.67, with an EV/FCF ratio of 55.36.

EV / Earnings	54.29
EV / Sales	8.85
EV / EBITDA	35.67
EV / EBIT	44.87
EV / FCF	55.36

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.58.

Current Ratio	1.23
Quick Ratio	0.67
Debt / Equity	0.58
Debt / EBITDA	2.82
Debt / FCF	4.36
Interest Coverage	5.58

Financial Efficiency

Return on equity (ROE) is 16.62% and return on invested capital (ROIC) is 9.12%.

Return on Equity (ROE)	16.62%
Return on Assets (ROA)	7.54%
Return on Invested Capital (ROIC)	9.12%
Return on Capital Employed (ROCE)	10.85%
Revenue Per Employee	6.25M
Profits Per Employee	1.02M
Employee Count	19,540
Asset Turnover	0.61
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.34% in the last 52 weeks. The beta is 0.53, so Mankind Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+16.34%
50-Day Moving Average	2,441.13
200-Day Moving Average	2,520.67
Relative Strength Index (RSI)	48.11
Average Volume (20 Days)	307,281

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mankind Pharma had revenue of INR 122.07 billion and earned 19.91 billion in profits. Earnings per share was 49.20.

Revenue	122.07B
Gross Profit	87.18B
Operating Income	23.97B
Pretax Income	25.16B
Net Income	19.91B
EBITDA	30.18B
EBIT	23.97B
Earnings Per Share (EPS)	49.20

Full Income Statement

Balance Sheet

The company has 22.45 billion in cash and 85.11 billion in debt, giving a net cash position of -62.66 billion or -151.84 per share.

Cash & Cash Equivalents	22.45B
Total Debt	85.11B
Net Cash	-62.66B
Net Cash Per Share	-151.84
Equity (Book Value)	145.68B
Book Value Per Share	347.44
Working Capital	13.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.13 billion and capital expenditures -4.61 billion, giving a free cash flow of 19.53 billion.

Operating Cash Flow	24.13B
Capital Expenditures	-4.61B
Free Cash Flow	19.53B
FCF Per Share	47.32

Full Cash Flow Statement

Margins

Gross margin is 71.42%, with operating and profit margins of 19.63% and 16.31%.

Gross Margin	71.42%
Operating Margin	19.63%
Pretax Margin	20.61%
Profit Margin	16.31%
EBITDA Margin	24.72%
EBIT Margin	19.63%
FCF Margin	16.00%

Dividends & Yields

Mankind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.87%
Shareholder Yield	n/a
Earnings Yield	1.96%
FCF Yield	1.92%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a